146 related articles for article (PubMed ID: 8160560)
1. Cyclosporine A in atopic dermatitis.
Gaig P; Alijotas J; López A; Valencia M; Cisteró A
Allergol Immunopathol (Madr); 1993; 21(5):169-72. PubMed ID: 8160560
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
[TBL] [Abstract][Full Text] [Related]
3. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
Czech W; Bräutigam M; Weidinger G; Schöpf E
J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
[TBL] [Abstract][Full Text] [Related]
4. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
5. [Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are dissociated from each other].
Munro CS; Higgins EM; Marks JM; Daly BM; Friedmann PS; Shuster S
Wien Med Wochenschr; 1991; 141(18-19):419-23. PubMed ID: 1776256
[TBL] [Abstract][Full Text] [Related]
6. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin maintenance therapy for severe atopic dermatitis.
Korstanje MJ; van de Staak WJ
Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
[TBL] [Abstract][Full Text] [Related]
8. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
9. Successful cyclosporine treatment for atopic dermatitis in a rhesus macaque (Macaca mulatta).
Ovadia S; Wilson SR; Zeiss CJ
Comp Med; 2005 Apr; 55(2):192-6. PubMed ID: 15884783
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Hanifin and Rajka's feature sets in adult atopic dermatitis patients.
Samochocki Z; Paulochowska E; Zabielski S
J Med; 2000; 31(3-4):177-82. PubMed ID: 11280449
[TBL] [Abstract][Full Text] [Related]
12. A case of atopic dermatitis-associated lichen amyloidosis successfully treated with oral cyclosporine and narrow band UVB therapy in succession.
Kang MJ; Kim HS; Kim HO; Park YM
J Dermatolog Treat; 2009; 20(6):368-70. PubMed ID: 19954395
[TBL] [Abstract][Full Text] [Related]
13. [Cyclosporin in atopic dermatitis].
Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R
Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717
[TBL] [Abstract][Full Text] [Related]
14. Montelukast treatment in children with moderately severe atopic dermatitis.
Ehlayel MS; Bener A; Sabbah A
Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
16. [Studies of allergen specific IgE antibodies with atopic dermatitis--evaluation of house dust 6 (house dust Japan) specific IgE antibody].
Takamura T; Nagata M; Nakagawa H; Hashimoto T
Rinsho Byori; 1996 Feb; 44(2):163-8. PubMed ID: 8851201
[TBL] [Abstract][Full Text] [Related]
17. [Results of skin prick tests and evaluation of serum antigen specific immunoglobulin E in patients with atopic dermatitis and airborne allergy with regards to the type of sensitising allergens and seasonal course of the disease].
Silny P; Czarnecka-Operacz M; Silny W
Pol Merkur Lekarski; 2005 Apr; 18(106):393-9. PubMed ID: 16161918
[TBL] [Abstract][Full Text] [Related]
18. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
Atakan N; Erdem C
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
[TBL] [Abstract][Full Text] [Related]
19. High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis.
Bemanian MH; Movahedi M; Farhoudi A; Gharagozlou M; Seraj MH; Pourpak Z; Nabavi M; Aghamohammadi A; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2005 Sep; 4(3):139-43. PubMed ID: 17301437
[TBL] [Abstract][Full Text] [Related]
20. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
